Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Today, ATS Labs, Inc. (ATS), majority owned by Ampersand Capital
Partners, announced that it acquired the assets of MicroTest Labs, Inc. (MTL) of Agawam, MA. The
acquisition of MTL is the first step in the strategy of ATS to expand its microbiology...
read more
ATUM (formerly DNA2.0) has announced an expansion of its services to include cell line development, which has been enabled by the company's proprietary Leap-In Transposase genome engineering tools. ATUM has also begun construction of a new, 7,000 SF...
read more
ATUM and Phylex BioSciences have entered into a collaboration to leverage ATUM's Leap-In Transposase® platform to develop the cell line essential to the manufacturing of Phylex's universal SARS coronavirus vaccine candidate.
read more
Tuesday, September 04, 2018
Catalent Pharma Solutions announced a commercial supply agreement for Aucta Pharmaceuticals (Aucta) vigabatrin.
read more
Audax Private Equity has entered into a definitive agreement to acquire the Clinical Services business of Avantor, Inc. The deal is expected to close in the fourth quarter and is subject to regulatory approvals.
read more
The American Urogynecologic Society announced the selection of Prometheus Research as its principal informatics partner.
read more
August Bioservices,LLC, a contract development and manufacturing organization (CDMO) providing drug discovery, development, and pharmaceutical manufacturing services, closed a $23.6 million Series A extension, led by Polaris Partners, who joined ...
read more
Thursday, December 01, 2022
August Bioservices, a CDMO providing drug discovery, development and pharmaceutical manufacturing services, announced $65 million in Series B funding led by Oak HC/FT, who led the Series A in July 2020. This round includes participation from existing...
read more
AUM Biosciences, a global clinical-stage biotech company, focused on discovering and developing novel targeted oncology therapies, has entered into a clinical trial collaboration and supply agreement with MSD, a tradename of Merck & Co., Inc., Rahway...
read more
Wednesday, October 21, 2020
MyMeds&Me announced Aurinia has selected the Reportum QuickStart platform to streamline the capture, processing and management of safety data for the investigational drug voclosporin.
read more
Aurinia Pharmaceuticals has selected Worldwide Clinical Trials as its Clinical Research Organization (CRO) for the AURORA Phase 3 study of volcosporin for the treatment of active lupus nephritis (LN).
read more
Wednesday, December 30, 2020
Aurinia Pharmaceuticals and Lonza have expanded their exclusive manufacturing relationship.
read more
Aurisco Pharmaceutical announced the expansion of its oligonucleotide manufacturing capacity and a new edition of its corporate website – www.aurisco.com.
read more
Wednesday, January 06, 2021
Aurobindo Pharma and COVAXX have entered into an agreement to develop, commercialize and manufacture UB-612, the first Multitope Peptide-based Vaccine to fight COVID-19, for India and UNICEF.
read more
Wednesday, December 27, 2017
AuroMedics Pharma is voluntarily recalling one lot of Pantoprazole Sodium for Injection 40 mg per vial, to the hospital level.
read more